Fidson to commission $38 million drug plant in Nigeria
Fidson Healthcare plc will commission a N7.5 billion (US$38 million) drug-making plant this year to offer more options in the Nigerian pharmaceutical industry and grow its portfolio.
The new facility will double the company’s production capacity and will, for the first time, add intravenous fluids to Fidson’s product portfolio. The facility is expected to conform to the World Health Organisation (Geneva)’s current Good.... Read more »
Posted on : Wednesday , 26th August 2015